Source:http://linkedlifedata.com/resource/pubmed/id/18471447
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
10
|
pubmed:dateCreated |
2008-5-12
|
pubmed:abstractText |
Traditional biomarkers in acute coronary syndromes reflect myocardial necrosis but not the underlying arteriosclerotic disease. Pregnancy-associated plasma protein A (PAPP-A) is a new biomarker in acute coronary syndromes that detects vulnerable plaques in arteriosclerotic disease and identifies acute coronary syndromes earlier than traditionally used biomarkers. Information regarding circulating PAPP-A levels in patients with ST elevation myocardial infarctions (STEMIs) is limited and contradictory. The aim of the present study was to describe the presence and time-related pattern of circulating PAPP-A levels in patients with STEMIs. Consecutive patients (n = 354) referred for primary percutaneous intervention because of STEMI were included in the study. Blood samples for the analysis of PAPP-A, creatine kinase-MB (CKMB), and troponin T were drawn at admission and every 6 to 8 hours until biomarkers of myocardial necrosis were consistently decreasing. PAPP-A was measured using a newly developed sandwich enzyme-linked immunosorbent assay technique based on 2 monoclonal antibodies. In total, 1,091 PAPP-A, 1,049 troponin T, and 1,016 CKMB samples were analyzed. Mean PAPP-A values at admission were significantly higher in patients with STEMIs than in those with non-ST elevation myocardial infarctions or unstable angina pectoris (27.6 vs 12.2 mIU/L, p <0.01). In samples drawn <2 hours after admission, the sensitivity of PAPP-A was superior (93%) to that of CKMB (60%) and troponin T (61%). In conclusion, PAPP-A levels are elevated in >90% of patients presenting with STEMIs if measured <6 hours after the onset of symptoms or <2 hours of primary percutaneous coronary intervention. In the early stages of STEMI, PAPP-A seems to be a more sensitive marker of myocardial infarction than CKMB and troponin T.
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0002-9149
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
101
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1389-94
|
pubmed:dateRevised |
2008-11-4
|
pubmed:meshHeading |
pubmed-meshheading:18471447-Biological Markers,
pubmed-meshheading:18471447-Coronary Angiography,
pubmed-meshheading:18471447-Creatine Kinase, MB Form,
pubmed-meshheading:18471447-Electrocardiography,
pubmed-meshheading:18471447-Female,
pubmed-meshheading:18471447-Humans,
pubmed-meshheading:18471447-Male,
pubmed-meshheading:18471447-Middle Aged,
pubmed-meshheading:18471447-Myocardial Infarction,
pubmed-meshheading:18471447-Predictive Value of Tests,
pubmed-meshheading:18471447-Pregnancy-Associated Plasma Protein-A,
pubmed-meshheading:18471447-Prognosis,
pubmed-meshheading:18471447-Retrospective Studies,
pubmed-meshheading:18471447-Severity of Illness Index,
pubmed-meshheading:18471447-Time Factors,
pubmed-meshheading:18471447-Troponin T
|
pubmed:year |
2008
|
pubmed:articleTitle |
Pregnancy associated plasma protein A, a novel, quick, and sensitive marker in ST-elevation myocardial infarction.
|
pubmed:affiliation |
The Heart Centre, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark. kasper.iversen@dadlnet.dk
|
pubmed:publicationType |
Journal Article,
Comparative Study
|